Nonselective COX inhibitors Flashcards
Phenylacetic acid derivative
Half life of 1.1 h ; <1% excreted unchanged in urine
Adverse effect : GI disturbance, occult GI bleeding, gastric ulceration
>150mg/dl = impaired renal blood flow and dec. GFR
Elevated serum AST/ALT
Diclofenac
Phenylpropionic acid
Dose of 2400mg daily and half life of 2h
*effective in closing PDA in preterm infants
Use with aspirin dec. its anti inflamm effect
Contraindicated in px with nasal polyps, angioedema, and bronchospastic reactivity
Antagonize the irreversible platelet inhibition caused by aspirin
Rare hematologic effect : agranulocytosis and aplastic anemia
Ibuprofen
Inhibit phospholipase A and C
Reduce neutrophil migration
Decrease T and B cell proliferation
Half life of 4-5h
*Probenecid prolongs the half life by inhibiting both renal and biliary clearance
Indicated for GOUT and ANKYLOSING SPONDYLITIS
Also for treatment of PDA and gingival inflamm
Adverse effects Headache Thrombocytopenia and aplastic anemia Hyperkalemia (due to dec. PG in kidneys) Renal papillary necrosis
Indomethacin
Propionic acid that inhibits BOTH COX(nonselectively) AND LOX
Half life of 1.8 h
*Probenecid prolongs its half life
Adverse effect on GIT and CNS
Ketoprofen
Mainly used as analgesic not as anti iflamm
Effective analgesic if given thru IM, IV, or oral
*may decrease opiod requirement by 25-50%
Used for opthalmic preparation for ocular imflamm conditions
Ketorolac
Inhibit both COX and phospholipase A2
Half life of 3h
Meclofemate and Mefenamic
*only NSAID that is marketed as a single enantiomer
Half life of 14h
Free fraction higher in women
Albumin binding very high in both sexes
Rare cases of allergic pneumonitis
Naproxen
Oxicam
High conc. inhibits PMN migration, decrease oxygen radical formation, and innibits lymphocyte function
Long half life : 57h
Adverse : GI disturbance, dizziness, tinnitus
*>20mg/dl = inc. risk for peptic ulcers
Risk 9.5 times higher than other NSAIDS
Piroxicam
Sulfoxide prodrug
Excreted in bile and reabsorbed in intestine
Half life of 8h
Enterohepatic cycling prolongs the duration of action to 12-16h
Suppress intestinal familial polyposis
Inhibit devt of colon, breast, prostate cancer
Sulindac
*only nonacid NSAID in current use
Half life of 26h (OD dose)
Do not enter enterohepatic circulation
Renal impairment doubles its half life and 30% inc. area under the curve
Adverse : pseudoporphyria and photosensitivity
Nabumetone
Propionic acid derivative
Very long half life (50-60h)
Do not enter enterohepatic circulation
Mildly uricosuric
Oxaprozin
Similar to oxicam
Long half life (72h)
Tenoxicam
Nonselective
Short half life (1-2h)
*ineffective for treating gout
May cause thrombocytopenic purpura
Tolmetin
From salicylic acid
Half life of 13h
500-1000mg daily (divided to 2 doses)
*effective for cancer pain from bone metastases
Limited to px with renal impairment
Diflunisal
Racemic acetic acid derivative
Half life of 6.5h
COX2:COX1 activity ratio of about 10
200-400 TID
Transient impairment of renal function
Etodolac